of the United States Patent and Trademark Office (USPTO), such matters are usually expensive, time-consuming, and arduous.

Femasys (FEMY) announces that the United States Patent and Trademark Office issued U.S. Patent No. 12,12796 covering FemBloc ...

Both novel bifunctional (SON-1411) and monofunctional (SON-1400) fusion proteins exhibit wild-type binding to the IL-18 ...

Samsung has filed a new patent for what appears to be an Augmented Reality (AR) headset. It hints at the design, purpose, and ...

Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that ...

GM has filed a patent for a two-tier loading system intended to enhance the usability of a pickup truck bed with flexible ...

The Drug Price Competition and Patent Term Restoration Act of 1984, better known as the Hatch-Waxman Act, is responsible for ...

Bailey submitted the trademark applications for “Speedball Mike Bailey” to the United States Patent and Trademark Office ...

FemBloc issued patent provides additional coverage for Femasys’ therapeutic option for women seeking permanent birth ...

edatanetworks Inc. announced today the approval of patent 18/385,505 from the United States Patent and Trademark Office (USPTO). This patent further strengthens edatanetworks' intellectual property ...

Yesterday (October 15), AEW filed a new trademark with the United States Patent & Trademark Office (USPTO) for the term "Fright Night Dynamite." The trademark was filed by All Elite Wrestling ...

Eton Pharmaceuticals (ETON) announced that the United States Patent and Trademark Office, USPTO, has granted the Company U.S. Patent Application No. 18/443,889, now U.S. Patent No. 12,133,914, for ...